Qiagen N.V. (ETR: QIA)

Market Cap	9.15B
Revenue (ttm)	1.76B
Net Income (ttm)	83.32M
Shares Out	n/a
EPS (ttm)	0.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	456,463
Open	40.25
Previous Close	40.22
Day's Range	40.25 - 41.12
52-Week Range	36.59 - 43.40
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2024

About Qiagen

Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids from secondary sample materials; and instruments for n...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 5,531
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: QIA

Financial Performance

In 2023, Qiagen's revenue was $1.97 billion, a decrease of -8.23% compared to the previous year's $2.14 billion. Earnings were $341.30 million, a decrease of -19.35%.

Financial numbers in USD